Nature Medicine's 38,753-Patient HF Synthesis Signals a Replicable Model for RWE-Driven ...

Nature Medicine published a large-scale synthesis of individual patient data from nine heart failure trials with 38,753 participants, demonstrating how pooled RCT data can achieve safety signal precision to support regulatory label expansions without new trials. This aligns with FDA guidance endorsing real-world evidence and data integration methods for regulatory decisions, especially for evaluating combination drug therapies in heart failure treatment.

This Wire brief sits within Fusion42's coverage of Health: Drug Discovery.